A Lifeline for Rare Diseases
ACHP calls on Congress to create a national risk pool for cutting-edge cell and gene therapies to mitigate high costs and ensure the right patients have access at a manageable cost.
Tag: prescription drugs / drug prices
PBM Transparency, Enhanced Premium Tax Credits in ACHP’s Year-End Priorities for Congress
ACHP recently sent a letter to Congress expressing the health care priorities we hope to see before the legislative session concludes.
ACHP Letter to Congress on Year-End Priorities
ACHP sent a letter encouraging Congress to act on key health care policies before the end of the 118th Congress.
ACHP Responds to Congressional RFI on Emerging Therapies and Health Information Technology
ACHP responded to a congressional RFI on legislation to advance emerging therapies and ease health information technology burdens
Provider-Aligned Health Plans Lead in Outcomes and Value
A new report from ACHP underscores how nonprofit, provider-aligned health plans are leading the industry in driving efficiencies resulting in improved outcomes for their communities.
